About CSI PHARMACEUTICA
Expense ratio
0.60%
Home page
Inception date
Dec 4, 2013
ISIN
CNE100001QY9
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region